Table 1. Patient characteristics.
| Characteristic | No. | % |
|---|---|---|
| Number of patients | 42 | 100 |
| Age (years) | ||
| Median (range) | 56 (25–74) | |
| Performance status (WHO) | ||
| 0 | 23 | 55 |
| 1 | 16 | 38 |
| 2 | 3 | 7 |
| Histology | ||
| Squamous | 35 | 83 |
| Adenosquamous | 5 | 12 |
| Adenocarcinoma | 2 | 5 |
| Previous treatment | ||
| Surgery alone | 2 | 4 |
| Surgery → radiation | 5 | 12 |
| Surgery → chemoradiation | 10 | 24 |
| Concurrent chemoradiation | 18 | 43 |
| None | 7 | 17 |
| Sites of tumour involvement | ||
| Within prior radiation field (pelvis) | 18 | 43 |
| Outside prior radiation field | 17 | 40 |
| Both | 7 | 17 |
| Metastatic sites | ||
| Lymph nodes | 36 | 86 |
| Pelvic mass | 26 | 62 |
| Lung | 12 | 29 |
| Liver | 3 | 7 |
| Bone | 2 | 4 |
| No. of sites with tumour involvement | ||
| 1 | 15 | 36 |
| 2 | 23 | 55 |
| >3 | 4 | 9 |
Abbreviation: WHO=World Health Organization.